All tenders
75N98026P00112
GMP Grade CRISPR Base-Editing Guide RNA for XSCID Patients
Department of Health and Human Services · MD, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N98026P00112
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- GMP Grade CRISPR Base-Editing Guide RNA for XSCID Patients
- Source
- usaspending
- Source ID
- CONT_AWD_75N98026P00112_7529_-NONE-_-NONE-
Details
- Location
- MD, United States
Summary
The National Institutes of Health is acquiring high-quality, Good Manufacturing Practice (GMP) grade CRISPR base-editing guide RNA specifically designed for treating patients with X-linked Severe Combined Immunodeficiency (XSCID), a rare genetic disorder.
Description
PURCHASE OF GMP GRADE CRISPR BASE-EDITING GUIDE RNA FOR XSCID PATIENTS AT THE CLINICAL CENTER. SYNTHEGO HOLDINGS LLC (AMBIS #2280586) Awarded to: SYNTHEGO HOLDINGS LLC Sub-agency: National Institutes of Health Contract type: PURCHASE ORDER
Dates
- Publication
- 2026/03/11 12:00:00 AM UTC
- Closing date
- 2027/03/10 12:00:00 AM UTC
Estimated value
$140K USD
Classification
Normalized category
Healthcare & Medical